Repligen (NASDAQ:RGEN) Stock Rating Lowered by Benchmark
Benchmark lowered shares of Repligen (NASDAQ:RGEN – Free Report) from a buy rating to a hold rating in a research note published on Monday morning, MarketBeat reports. Other equities analysts have also issued reports about the stock. Royal Bank of Canada decreased their target price on shares of Repligen from $207.00 to $200.00 and set […]
More Stories
McKesson (NYSE:MCK) Issues FY 2025 Earnings Guidance
McKesson (NYSE:MCK – Get Free Report) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share...
M. Kraus & Co Cuts Position in Thermo Fisher Scientific Inc. (NYSE:TMO)
M. Kraus & Co cut its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 0.2%...
Financial Survey: Gold Royalty (NYSE:GROY) & American International Ventures (OTCMKTS:AIVN)
Gold Royalty (NYSE:GROY – Get Free Report) and American International Ventures (OTCMKTS:AIVN – Get Free Report) are both small-cap basic...
iShares Bitcoin Trust (NASDAQ:IBIT) Shares Up 3.1% – What’s Next?
iShares Bitcoin Trust (NASDAQ:IBIT – Get Free Report)’s share price rose 3.1% during trading on Wednesday . The company traded...
Red Cat (NASDAQ:RCAT) Stock Price Up 17.1% – Still a Buy?
Red Cat Holdings, Inc. (NASDAQ:RCAT – Get Free Report) shares were up 17.1% on Wednesday . The company traded as...
Silvia Mccoll Wealth Management LLC Raises Stock Position in Vanguard Small-Cap Value ETF (NYSEARCA:VBR)
Silvia Mccoll Wealth Management LLC grew its stake in Vanguard Small-Cap Value ETF (NYSEARCA:VBR – Free Report) by 1.3% in...